BIO 2019 in Philadelphia: BIO Deutschland is rapporteur for the BMWi

BIO Deutschland’s Matthias Bach and Claudia Englbrecht at the German Pavilion’s information stand © BIO Deutschland

The BIO International Convention, the largest global event for the biotechnology industry, was held in Philadelphia from 3 to 6 June. BIO Deutschland travelled to the birthplace of the United States as the official rapporteur for the German Federal Ministry for Economic Affairs and Energy (BMWi).
The BMWi supports German companies at BIO as part of its Foreign Trade Fair Programme by organising the German Pavilion.

Germany was once again represented by a large delegation. A total of 46 exhibitors, companies and BioRegions – including many members of BIO Deutschland – were represented at the German Pavilion, and more than twenty firms presented themselves at their own stands.

BIO Deutschland ran the Pavilion’s central information stand and provided visitors with detailed information on the exhibitors, the German biotechnology sector and German biotechnology companies. It was supported on the stand by staff from the Health – Made in Germany export initiative, which is implemented by the economic development agency Germany Trade & Invest (GTAI).

In addition to running the information stand, Claudia Englbrecht moderated an education session entitled “Referencing European Prices for Medicare Part B Drugs”, in which experts provided an overview of the different health technology assessment (HTA) frameworks in Europe as well as of the European reference price system. Key topics discussed included how the Trump government’s plan to reference European drug prices would affect the pricing of Medicare Part B drugs.

Just under 17,300 visitors from 65 countries attended this year’s event in Philadelphia. More than 48,000 scheduled partnering meeting took place – a new record for the event. The convention will return to the west coast next year, with San Diego set to host the event from 8 to 11 June 2020.

Go back